Gastrointestinal Cancer News

Nivolumab appeared safe and effective in the treatment of patients with esophageal cancer, according to results of a phase 2 clinical trial.

The FDA granted breakthrough therapy designation to entrectinib for the treatment of NTRK fusion–positive locally advanced or metastatic solid tumors, according to the drug’s manufacturer.

In vulnerable primary care patients, an intervention that combined a patient decision aid and patient navigation substantially increased the rate of colorectal cancer screening completion compared with usual care, according to research published in JAMA Internal Medicine.

The FDA granted orphan drug designation to larotrectinib for the treatment of solid tumors with neurotrophic tyrosine receptor kinase–fusion proteins, according to the drug’s manufacturer.

Higher doses of radiotherapy may prolong survival for patients with early-stage pancreatic cancer, according to study results presented at ESTRO 36, the meeting of the European Society for Radiotherapy and Oncology.

The Esophageal Cancer Action Network filed a citizen’s petition with the FDA, asking the agency to require labels on over-the-counter reflux medications to warn consumers about the association between persistent heartburn and esophageal cancer.

CHICAGO — Despite improved access to care, racial, ethnic and socioeconomic disparities persist in colorectal cancer screening, particularly among Hispanic people, according to a presentation at Digestive Disease Week.

Array BioPharma and Merck entered into a clinical trial collaboration agreement to evaluate binimetinib in combination with pembrolizumab for the treatment of patients with metastatic colorectal cancer who have microsatellite stable tumors.

County-level cancer incidence rates appeared higher in areas with poor environmental quality, according to study results published in Cancer.

Theresa M. McDonnell, DNP, has been named chief nurse executive and vice president of clinical operations at Seattle Cancer Care Alliance.